A Guide to Twin-to-Twin Transfusion Syndrome (TTTs)

24 October 2024

Learn about Twin-to-Twin Transfusion Syndrome, its causes, treatment options & implications for medical negligence claims if care standards are not met.

“These claims are complicated and difficult because there are risks inherent with any treatment and especially so with high-risk pregnancy.

Although these cases are rare, with the right treatment and continuous monitoring, TTTS can be managed  whilst being conscious of the inherent risks of high-risk pregnancies.”

- Andrea Rusbridge, Serious Injury Partner

What is Twin to Twin Transfusion Syndrome (TTTs)?

Twin to Twin Transfusion Syndrome (TTTS) is a rare condition where one twin receives too much blood and the other too little through a shared placenta. It is caused by abnormal connecting blood vessels in the twins' placenta (Antenatal care with twins - NHS (www.nhs.uk)).

TTTS affects around 10-15% of identical twins that share the same blood supply through the placenta. Also known as Monochorionic diamniotic twins, MCDA occurs in about 1 in 300 pregnancies. TTS is usually diagnosed between 18 – 20 weeks gestation.

This condition can be life-threatening to one or both twins if they are not regularly monitored through ultrasound scans. If TTTS is left untreated, there is a risk of death for one or both twins due to a lack of blood and oxygen reaching vital organs.

What is the available treatment for TTTS?

One form of treatment for this condition is laser therapy, which can split the placenta to resolve TTTS.  However deep vessels within the placenta are not visible to doctors when performing this treatment and therefore it is possible for TTTS to return.

In the event there is a possibility of premature labour, steroid injections can be administered to assist babies with the development of their lungs to help them breathe. (www.nhs.uk/pregnancy/labour-and-birth/signs-of-labour/premature-labour-and-birth/)

This was the case for a mother in Northampton. She was informed there were concerns of early labour and therefore steroid injections were administered before 28 weeks, to help with lung development in her twins.  A decision was made to undergo an emergency caesarean section and happily, her twins were born healthy at 32 weeks.

Our client

Such early interventions are essential in these cases. Andrea Rusbridge, a clinical negligence specialist, is acting for a client who was pregnant with MCDA identical twins with TTTS. We are exploring a claim for one of the twins, who suffered from a brain injury and has been diagnosed with cerebral palsy due to the delay in delivery.  Check out our page on twin birth injury claims, for more information on the processes involved in making a claim.

Share

Disclaimer

This information is for educational purposes only and does not constitute legal advice. It is recommended that specific professional advice is sought before acting on any of the information given. © Shoosmiths LLP 2024

Contact our experts

Sorry, there are a few problems with the information you have entered. Please correct these before continuing.

Submitting

One moment please...

Thank You

Your submission has been received. We'll be in touch soon.

Who we work with

  • Brain Injury Group
  • CESS
  • ABIF
  • Headway
  • SIA
  • Back Up
  • BABICM
  • Bens Heroes Trust

Our accreditations

  • Accredited Personal Injury
  • Apil
  • Avma
  • Clinical Negligence
  • Legal 500
  • UK Chambers
  • The Society Of Clinical Injury Lawyers

What our clients say